AstraZeneca Expands Phase III COVID-19 Vaccine Trial into the U.S.
Felicia Rodriguez
September 1, 2020
Via: https://www.biospace.com/article/astrazeneca-expands-phase-iii-covid-19-vaccine-trial-into-the-u-s-/ AstraZeneca announced that its Phase III clinical trial of its COVID-19 vaccine candidate, AZD1222, is expanding into the U.S. It will be dubbed D8110C00001 and is funded by the Biomedical Advanced Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The